المنشورات طباعة Oviedo P, Burns S, Chen WP, Mandl HK, Rosso C, Radgoudarzi N, Crosetti A, Zamora S, Perry LM, Bold RJ, Labora AN, Donahue TR, Maker A, Valerin JB, Zell JA, White RR. The impact of the California state lockdown during the COVID-19 pandemic on management of patients with pancreatic ductal adenocarcinoma. J Surg Oncol. 2024 Aug; 130 (2):276-283 Epub 2024 June 18 View PubMed Wang SS, Hall ML, Lee E, Kim SC, Ramesh N, Lee SH, Jang JY, Bold RJ, Ku JL, Hwang CI. Whole-genome bisulfite sequencing identifies stage- and subtype-specific DNA methylation signatures in pancreatic cancer. iScience. 2024 Apr 19; 27 (4):109414 Epub 2024 Mar 04 View PubMed Persky J, Cruz SM, Darrow MA, Judge SJ, Li Y, Bold RJ, Karnezis AN, Matsukuma KE, Qi L, Canter RJ. Characterization of natural killer and cytotoxic T-cell immune infiltrates in pancreatic ductal adenocarcinoma. J Surg Oncol. 2024 Apr; 129 (5):885-892 Epub 2024 Jan 09 View PubMed Abidi H, Bold RJ. Assessing the Sentimag system for guiding sentinel node biopsies in patients with breast cancer. Expert Rev Med Devices. 2024 Jan-Feb; 21 (1-2):1-9 Epub 2024 Feb 04 View PubMed Perry LM, Canter RJ, Gaskill CE, Bold RJ. Regionalization of pancreatic surgery in California: Benefits for preventing postoperative deaths and reducing healthcare costs. Surg Open Sci. 2023 Dec; 16:198-204 Epub 2023 Nov 20 View PubMed Utter GH, Rajasekar G, Nuno M, Bold RJ. Optimal Definition of Pancreaticoduodenectomy in the International Classification of Diseases, 10th Revision, Procedure Coding System. Med Care. 2023 Oct 1; 61 (10):651-656 Epub 2023 Aug 09 View PubMed Perry LM, Keegan THM, Li Q, Bold RJ, Antonino NF, Maguire FB, Sauder CAM. Survival After Contralateral Secondary Breast Cancer by Age Group in California. Ann Surg Oncol. 2023 Oct; 30 (10):6178-6187 Epub 2023 July 17 View PubMed Gaskill CE, Bold RJ. Impact on patient outcomes after regionalization of pancreatic surgery. J Gastrointest Oncol 2023 Aug 31; 14 (4):1909-1912 Epub 2023 July 04 View PubMed Sauder CAM, Abidi H, Bold RJ. Shifting paradigms for the treatment of ductal carcinoma in situ: Less is more. Surgery. 2023 Jul; 174 (1):129-130 Epub 2023 Apr 15 View PubMed Perry LM, Kleber KT, Rajasekar G, Nuño M, Bold RJ. The Impact of Preexisting Psychiatric Disorders on Outcomes After Pancreatic Cancer Surgery. Pancreas. 2022 Nov-Dec 01; 51(10):1376-1380. View PubMed Perry LM, Bateni SB, Merkow RP, Canter RJ, Bold RJ, Hallet J, Gholami S. Evaluation of Adherence to Venous Thromboembolism Prophylaxis Guidelines Among US Adults After Pancreatic Cancer Surgery. JAMA Surg. 2022 Sep 1; 157 (9):850-852 View PubMed Perry LM, Bold RJ. Power Analysis in Clinical Trial Design. Ann Surg Oncol 2022 Sep; 29 (9):5826-5827 Epub 2022 July 08 View PubMed Perry LM, Burgess D, Bold RJ. Improvements in cancer care through changes implemented during the COVID-19 pandemic. Am J Surg 2022 Jul; 224 (1 Pt B):643-644 Epub 2022 Feb 16 View PubMed Perry LM, Bold RJ, Hoch JS. Cost-Effectiveness Analysis and Volume-Based Surgical Care. J Am Coll Surg 2022 Feb 1; 234 (2):249-250 View PubMed Sauder CAM, Li Q, Bold RJ, Ruddy KJ, Keegan THM. Secondary Breast Cancer Sociodemographic Characteristics and Survival by Age Group. Ann Surg Oncol. 2021 Dec; 28(13):8118-8127. Epub 2021 Jun 29. View PubMed Perry LM, Bold RJ. Analysis of Revenue, Expense, and Profitability in Surgical Procedures. J Am Coll Surg 2021 Dec; 233 (6):813-814 Epub 2021 Sept 20 View PubMed Bateni SB, Gingrich AA, Kirane AR, Sauder CAM, Gholami S, Bold RJ, Meyers FJ, Canter RJ. Chemotherapy After Diagnosis of Malignant Bowel Obstruction is Associated with Superior Survival for Medicare Patients with Advanced Malignancy. Ann Surg Oncol. 2021 Nov; 28 (12):7555-7563 Epub 2021 Apr 07 View PubMed Perry LM, Bateni SB, Bold RJ, Hoch JS. Is Improved Survival in Early-Stage Pancreatic Cancer Worth the Extra Cost at High-Volume Centers? J Am Coll Surg. 2021 Jul; 233 (1):90-98 Epub 2021 Mar 22 View PubMed Bateni SB, Perry LM, Zhao X, Arora M, Daly ME, Stewart SL, Bold RJ, Canter RJ, Sauder CAM. The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis. Ann Surg Oncol. 2021 May; 28 (5):2463-2471 Epub 2020 Oct 22 View PubMed Cinar P, Bold R, Bosslet BA, Bota DA, Burgess D, Chew HK, Cohen JG, Elquza E, Gold KA, Kamiya E, Karlan BY, McKay RR, Patel SP, Ternavan K, Welborn J, Yamamoto M, Rugo HS. Planning for post-pandemic cancer care delivery: Recovery or opportunity for redesign? CA Cancer J Clin. 2021 Jan; 71 (1):34-46 Epub 2020 Sept 30 View PubMed Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK. Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2020 Dec; 27 (Suppl 3):979 View PubMed Tu MJ, Duan Z, Liu Z, Zhang C, Bold RJ, Gonzalez FJ, Kim EJ, Yu AM. MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis. Mol Pharmacol. 2020 Dec; 98 (6):686-694 Epub 2020 Oct 13 View PubMed Sauder CAM, Li Q, Othieno A, Cruz D, Arora M, Bold RJ, Meyers FJ, Keegan THM. Characteristics and Outcomes for Secondary Breast Cancer in Childhood, Adolescent, and Young Adult Cancer Survivors Treated with Radiation. Cancer Epidemiol Biomarkers Prev. 2020 Sep; 29 (9):1767-1774 View PubMed Ngo V, Matsumoto CG, Joseph JG, Bell JF, Bold RJ, Davis A, Reed SC, Kim KK. The Personal Health Network Mobile App for Chemotherapy Care Coordination: Qualitative Evaluation of a Randomized Clinical Trial. JMIR Mhealth Uhealth. 2020 May 26; 8 (5):e16527 View PubMed Bateni SB, Johns AJ, Gingrich AA, Gholami S, Bold RJ, Canter RJ, Kirane AR. Elderly Age Is Associated With More Conservative Treatment of Invasive Melanoma. Anticancer Res. 2020 May; 40 (5):2895-2903 View PubMed Unger J, Hebisch C, Phipps JE, Lagarto JL, Kim H, Darrow MA, Bold RJ, Marcu L. Real-time diagnosis and visualization of tumor margins in excised breast specimens using fluorescence lifetime imaging and machine learning. Biomed Opt Express. 2020 Mar 1; 11 (3):1216-1230 Epub 2020 Feb 14 View PubMed Amend G, Palvolgyi R, Rodriguez VM, Bold RJ, Evans CP. A Case Series of Preoperative Endovascular Stenting in Patients Undergoing Postchemotherapy Resection of Complex Oncologic Masses. Eur Urol Oncol. 2020 Feb; 3 (1):1-6 Epub 2019 Dec 28 View PubMed Judge SJ, Ji J, Liu J, Kaur M, Kim E, Gong J, Tam KW, Kirane AR, Gholami S, Canter RJ, Bold RJ, Gangi A, Fakih M, Cho M. The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report. Front Oncol. 2020; 10:581 Epub 2020 Apr 21 View PubMed Cai D, Wang J, Gao B, Li J, Wu F, Zou JX, Xu J, Jiang Y, Zou H, Huang Z, Borowsky AD, Bold RJ, Lara PN, Li JJ, Chen X, Lam KS, To KF, Kung HJ, Fiehn O, Zhao R, Evans RM, Chen HW. RORgamma is a targetable master regulator of cholesterol biosynthesis in a cancer subtype. Nat Commun. 2019 Oct 11; 10 (1):4621 View PubMed Bateni SB, Gingrich AA, Hoch JS, Canter RJ, Bold RJ. Defining Value for Pancreatic Surgery in Early-Stage Pancreatic Cancer. JAMA Surg. 2019 Oct 1; 154 (10):e193019 Epub 2019 Oct 16 View PubMed Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2019 Oct; 26 (11):3510-3516 Epub 2019 July 11 View PubMed Chen JA, Esteghamat N, Kim EJ, Garcia G, Gong J, Fakih MG, Bold RJ, Cho MT. PD-1 Blockade in a Liver Transplant Recipient With Microsatellite Unstable Metastatic Colorectal Cancer and Hepatic Impairment. J Natl Compr Canc Netw. 2019 Sep 1; 17 (9):1026-1030 View PubMed Judge SJ, Lata-Arias K, Yanagisawa M, Darrow MA, Monjazeb AM, Kirane AR, Bold RJ, Canter RJ, Canter DJ. Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis. J Surg Oncol. 2019 Sep; 120 (4):753-760 Epub 2019 July 29 View PubMed Bateni SB, Gingrich AA, Jeon SY, Hoch JS, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. Clinical Outcomes and Costs Following Unplanned Excisions of Soft Tissue Sarcomas in the Elderly. J Surg Res. 2019 Jul; 239:125-135 Epub 2019 Feb 27 View PubMed Bateni SB, Davidson AJ, Arora M, Daly ME, Stewart SL, Bold RJ, Canter RJ, Sauder CAM. Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis. Ann Surg Oncol. 2019 Jul; 26 (7):2144-2153 Epub 2019 Feb 13 View PubMed Gingrich AA, Bateni SB, Monjazeb AM, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. Extremity soft tissue sarcoma in the elderly: Are we overtreating or undertreating this potentially vulnerable patient population? J Surg Oncol. 2019 Jun; 119 (8):1087-1098 Epub 2019 Apr 12 View PubMed Brown EG, Bateni SB, Burgess D, Li CS, Bold RJ. Interhospital Variability in Quality Outcomes of Pancreatic Surgery. J Surg Res. 2019 Mar; 235:453-458 Epub 2018 Nov 21 View PubMed Hausner SH, Bold RJ, Cheuy LY, Chew HK, Daly ME, Davis RA, Foster CC, Kim EJ, Sutcliffe JL. Preclinical Development and First-in-Human Imaging of the Integrin alpha(v)beta(6) with [(18)F]alpha(v)beta(6)-Binding Peptide in Metastatic Carcinoma. Clin Cancer Res. 2019 Feb 15; 25 (4):1206-1215 Epub 2018 Nov 06 View PubMed Tu MJ, Ho PY, Zhang QY, Jian C, Qiu JX, Kim EJ, Bold RJ, Gonzalez FJ, Bi H, Yu AM. Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models. Cancer Lett. 2019 Feb 1; 442:82-90 Epub 2018 Oct 30 View PubMed Whitney RL, Bell JF, Tancredi DJ, Romano PS, Bold RJ, Wun T, Joseph JG. Unplanned Hospitalization Among Individuals With Cancer in the Year After Diagnosis. J Oncol Pract. 2019 Jan; 15 (1):e20-e29 Epub 2018 Dec 05 View PubMed Bateni SB, Olson JL, Hoch JS, Canter RJ, Bold RJ. Drivers of Cost for Pancreatic Surgery: It's Not About Hospital Volume. Ann Surg Oncol. 2018 Dec; 25 (13):3804-3811 Epub 2018 Sept 14 View PubMed Olson JL, Bold RJ. Currently available first-line drug therapies for treating pancreatic cancer. Expert Opin Pharmacother. 2018 Dec; 19(17):1927-1940. Epub 2018 Oct 16. View PubMed Bateni SB, Gingrich AA, Stewart SL, Meyers FJ, Bold RJ, Canter RJ. Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management. BMC Cancer. 2018 Nov 26; 18 (1):1166 View PubMed Bateni SB, Canter RJ, Meyers FJ, Galante JM, Bold RJ. Palliative Care Training and Decision-Making for Patients with Advanced Cancer: A Comparison of Surgeons and Medical Physicians. Surgery. 2018 Apr 27 [Epub ahead of print] View PubMed Yanagisawa M, Gingrich AA, Judge S, Li CS, Wang N, Thorpe SW, Kirane AR, Bold RJ, Monjazeb AM, Canter RJ. Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma. Anticancer Res. 2018 Mar; 38 (3):1491-1497 View PubMed Bateni SB, Bold RJ, Meyers FJ, Canter DJ, Canter RJ. Comparison of common risk stratification indices to predict outcomes among stage IV cancer patients with bowel obstruction undergoing surgery. J Surg Oncol. 2018 Mar; 117 (3):479-487 Epub 2017 Oct 16 View PubMed Reed SC, Bell JF, Whitney R, Lash R, Kim KK, Bold RJ, Joseph JG. Psychosocial outcomes in active treatment through survivorship. Psychooncology. 2018 Jan; 27 (1):279-285 Epub 2017 May 18 View PubMed Unger J, Sun T, Chen YL, Phipps JE, Bold RJ, Darrow MA, Ma KL, Marcu L. Method for accurate registration of tissue autofluorescence imaging data with corresponding histology: a means for enhanced tumor margin assessment. J Biomed Opt. 2018 Jan; 23 (1):1-11 View PubMed Phipps JE, Gorpas D, Unger J, Darrow M, Bold RJ, Marcu L. Automated detection of breast cancer in resected specimens with fluorescence lifetime imaging. Phys Med Biol. 2017 Dec 14; 63 (1):015003 View PubMed Whitney RL, Bell JF, Tancredi DJ, Romano PS, Bold RJ, Joseph JG. Hospitalization Rates and Predictors of Rehospitalization Among Individuals With Advanced Cancer in the Year After Diagnosis. J Clin Oncol. 2017 Nov 1; 35 (31):3610-3617 Epub 2017 Aug 29 View PubMed Gingrich AA, Bateni SB, Monjazeb AM, Darrow MA, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis. Ann Surg Oncol. 2017 Oct; 24 (11):3252-3263 Epub 2017 July 24 View PubMed Park JS, Bateni SB, Bold RJ, Kirane AR, Canter DJ, Canter RJ. The modified frailty index to predict morbidity and mortality for retroperitoneal sarcoma resections. J Surg Res. 2017 Sep; 217:191-197 Epub 2017 May 11 View PubMed Bateni SB, David EA, Bold RJ, Cooke DT, Meyers FJ, Canter RJ. Lung resection is safe and feasible among stage IV cancer patients: An American College of Surgeons National Surgical Quality Improvement Program analysis. Surgery. 2017 May; 161 (5):1307-1314 Epub 2016 Dec 20 View PubMed Bell JF, Whitney RL, Reed SC, Poghosyan H, Lash RS, Kim KK, Davis A, Bold RJ, Joseph JG. Systematic Review of Hospital Readmissions Among Patients With Cancer in the United States. Oncol Nurs Forum. 2017 Mar 1; 44 (2):176-191 View PubMed Lash RS, Bell JF, Bold RJ, Joseph JG, Cress RD, Wun T, Brunson AM, Romano PS. Emergency department use by recently diagnosed cancer patients in California. J Community Support Oncol. 2017 Mar-Apr; 15 (2):95-102 View PubMed Lash RS, Bell JF, Reed SC, Poghosyan H, Rodgers J, Kim KK, Bold RJ, Joseph JG. A Systematic Review of Emergency Department Use Among Cancer Patients. Cancer Nurs. 2017 Mar/Apr; 40 (2):135-144 View PubMed Brown EG, Anderson JE, Burgess D, Bold RJ, Farmer DL. Pediatric surgical readmissions: Are they truly preventable? J Pediatr Surg. 2017 Jan; 52 (1):161-165 Epub 2016 Oct 28 View PubMed Bold RJ. Biology Trumps Anatomic Location in Periampullary Cancers. JAMA Surg 2017 Jan 1; 152 (1):89 View PubMed Brown EG, Anderson JE, Burgess D, Bold RJ. Examining the "Halo Effect" of Surgical Care Within Health Systems. JAMA Surg. 2016 Oct 1; 151 (10):983-984 View PubMed Whitney RL, Bell JF, Reed SC, Lash R, Bold RJ, Kim KK, Davis A, Copenhaver D, Joseph JG. Predictors of financial difficulties and work modifications among cancer survivors in the United States. J Cancer Surviv. 2016 Apr; 10 (2):241-50 Epub 2015 July 19 View PubMed Yuen NK, Li CS, Monjazeb AM, Borys D, Bold RJ, Canter RJ. Older Age Modifies Oncologic Outcome Following Radiotherapy in Soft-tissue Sarcoma: A Subtype-specific SEER Analysis. Anticancer Res. 2016 Apr; 36 (4):1745-50 View PubMed Bateni SB, Meyers FJ, Bold RJ, Canter RJ. Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical Practice. PLoS One. 2016; 11 (10):e0165315 Epub 2016 Oct 25 View PubMed Kim KK, Bell JF, Bold R, Davis A, Ngo V, Reed SC, Joseph JG. A Personal Health Network for Chemotherapy Care Coordination: Evaluation of Usability Among Patients. Stud Health Technol Inform. 2016; 225:232-6 View PubMed Dyer BA, Kahn LA, Matin M, Bold RJ, Tanaka MI, Monjazeb AM. Long-Term Progression-Free Survival in a Patient with Locally Advanced, Unresectable Pancreatic Adenocarcinoma. Cureus. 2015 Dec 15; 7 (12):e406 View PubMed Yuen NK, Li CS, Monjazeb AM, Borys D, Bold RJ, Canter RJ. Older age impacts radiotherapy-related outcomes in soft tissue sarcoma. J Surg Res. 2015 Dec; 199 (2):494-504 Epub 2015 June 16 View PubMed Bateni SB, Meyers FJ, Bold RJ, Canter RJ. Current perioperative outcomes for patients with disseminated cancer. J Surg Res. 2015 Jul; 197 (1):118-25 Epub 2015 Mar 27 View PubMed Kim EJ, Semrad TJ, Bold RJ. Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers. Expert Opin Investig Drugs. 2015 Jun; 24 (6):781-94 Epub 2015 Mar 25 View PubMed Brown EG, Canter RJ, Bold RJ. Preoperative CA 19-9 kinetics as a prognostic variable in radiographically resectable pancreatic adenocarcinoma. J Surg Oncol. 2015 Mar; 111 (3):293-8 Epub 2014 Oct 20 View PubMed Mayadev J, Einck J, Elson S, Rugo H, Hwang S, Bold R, Daroui P, McCloskey S, Yashar C, Kim D, Fowble B. Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network. Clin Breast Cancer. 2015 Feb; 15 (1):43-7 Epub 2014 Aug 15 View PubMed Brown EG, Bold RJ. Hospital Readmissions: Are They Preventable? Adv Surg. 2015; 49:15-29 Epub 2015 Apr 22 View PubMed Whitney RL, Bell JF, Bold RJ, Joseph JG. Mental health needs and service use in a national sample of adult cancer survivors in the USA: has psychosocial care improved? Psychooncology. 2015 Jan; 24 (1):80-8 Epub 2014 May 13 View PubMed Daylami R, Muilenburg DJ, Virudachalam S, Bold RJ. Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer. J Exp Clin Cancer Res. 2014 Dec 12; 33 (1):102 View PubMed Brown EG, Burgess D, Li CS, Canter RJ, Bold RJ. Hospital readmissions: necessary evil or preventable target for quality improvement. Ann Surg. 2014 Oct; 260 (4):583-9; discussion 589-91 View PubMed Changou CA, Chen YR, Xing L, Yen Y, Chuang FY, Cheng RH, Bold RJ, Ann DK, Kung HJ. Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy. Proc Natl Acad Sci U S A. 2014 Sep 30; 111 (39):14147-52 Epub 2014 Aug 13 View PubMed Shah DR, Bold RJ, Yang AD, Khatri VP, Martinez SR, Canter RJ. Relative value units poorly correlate with measures of surgical effort and complexity. J Surg Res. 2014 Aug; 190 (2):465-70 Epub 2014 May 23 View PubMed Brown EG, Yang A, Canter RJ, Bold RJ. Outcomes of pancreaticoduodenectomy: where should we focus our efforts on improving outcomes? JAMA Surg. 2014 Jul; 149 (7):694-9 View PubMed Muilenburg D, Parsons C, Coates J, Virudachalam S, Bold RJ. Role of autophagy in apoptotic regulation by Akt in pancreatic cancer. Anticancer Res. 2014 Feb; 34 (2):631-7 View PubMed Mayadev J, Daly M, Chen A, Bold R, Chew H. The potential role of radiation therapy to the primary site of disease in stage IV breast cancer presenting with synchronous metastasis. Clin Breast Cancer. 2014 Feb; 14 (1):10-2 Epub 2013 Oct 30 View PubMed Shah DR, Martinez SR, Canter RJ, Yang AD, Bold RJ, Khatri VP. Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses. J Surg Oncol. 2013 Dec; 108 (7):472-6 Epub 2013 Sept 21 View PubMed Shah DR, Galante JM, Bold RJ, Canter RJ, Martinez SR. Text messaging among residents and faculty in a university general surgery residency program: prevalence, purpose, and patient care. J Surg Educ. 2013 Nov-Dec; 70 (6):826-34 Epub 2012 June 15 View PubMed Canter RJ, Smith CA, Martinez SR, Goodnight JE Jr, Bold RJ, Wisner DH. Extremity soft tissue tumor surgery by surgical specialty: a comparison of case volume among oncology and non-oncology-designated surgeons. J Surg Oncol. 2013 Sep; 108 (3):142-7 Epub 2013 July 03 View PubMed Shah DR, Wang H, Bold RJ, Yang X, Martinez SR, Yang AD, Khatri VP, Wisner DH, Canter RJ. Nomograms to predict risk of in-hospital and post-discharge venous thromboembolism after abdominal and thoracic surgery: an American College of Surgeons National Surgical Quality Improvement Program analysis. J Surg Res. 2013 Jul; 183 (1):462-71 Epub 2013 Jan 02 View PubMed Chae AW, Vandewalker KM, Li YJ, Beckett LA, Ramsamooj R, Bold RJ, Khatri VP. Quantitation of sentinel node metastatic burden and Her-2/neu over-expression accurately predicts residual axillary nodal involvement and extranodal disease in breast cancer. Eur J Surg Oncol. 2013 Jun; 39 (6):627-33 Epub 2013 Mar 21 View PubMed Changou CA, Wolfson DL, Ahluwalia BS, Bold RJ, Kung HJ, Chuang FY. Quantitative analysis of autophagy using advanced 3D fluorescence microscopy. J Vis Exp. 2013 May 3; (75):e50047 Epub 2013 May 03 View PubMed Shah DR, Brown E, Russo JE, Li CS, Martinez SR, Coates JM, Bold RJ, Canter RJ. Negligible effect of perioperative epidural analgesia among patients undergoing elective gastric and pancreatic resections. J Gastrointest Surg. 2013 Apr; 17 (4):660-7 Epub 2013 Jan 24 View PubMed Shah DR, Canter RJ, Khatri VP, Bold RJ, Yang AD, Martinez SR. Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy. Ann Surg Oncol. 2013 Jan; 20 (1):24-30 Epub 2012 Sept 28 View PubMed Bold RJ, von Friederichs-Fitzwater MM, Kugelmass J, Heifetz L, Christensen S, deVere White S, Meyers F. Virtual Tumor Boards: Community-University Collaboration to Improve Quality of Care. Community Oncology. 2013; 10(11):310-5. Martinez SR, Shah DR, Tseng WH, Canter RJ, Bold RJ. Rural-urban disparities in use of post-lumpectomy radiation. Med Oncol. 2012 Dec; 29 (5):3250-7 Epub 2012 June 09 View PubMed Shah DR, Canter RJ, Khatri VP, Bold RJ, Martinez SR. Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy. J Surg Res. 2012 Sep; 177 (1):e21-6 Epub 2012 Mar 30 View PubMed Martinez SR, Tseng WH, Shah DR, Canter RJ, Bold RJ. Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer. Med Oncol. 2012 Sep; 29 (3):1523-8 Epub 2011 Oct 08 View PubMed Shah D, Borys D, Martinez SR, Li CS, Tamurian RM, Bold RJ, Monjazeb A, Canter RJ. Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res. 2012 Sep; 32 (9):3911-5 View PubMed Smith CA, Martinez SR, Tseng WH, Tamurian RM, Bold RJ, Borys D, Canter RJ. Predicting survival for well-differentiated liposarcoma: the importance of tumor location. J Surg Res. 2012 Jun 1; 175 (1):12-7 Epub 2011 Aug 10 View PubMed Martinez SR, Tseng WH, Canter RJ, Chen AM, Chen SL, Bold RJ. Do radiation use disparities influence survival in patients with advanced breast cancer? Cancer. 2012 Jan 1; 118 (1):196-204 Epub 2011 June 20 View PubMed Tseng WH, Canter RJ, Bold RJ. Perioperative outcomes for open distal pancreatectomy: current benchmarks for comparison. J Gastrointest Surg. 2011 Nov; 15 (11):2053-8 Epub 2011 Sept 22 View PubMed Martinez SR, Beal SH, Canter RJ, Chen SL, Khatri VP, Bold RJ. Medullary carcinoma of the breast: a population-based perspective. Med Oncol. 2011 Sep; 28 (3):738-44 View PubMed Tseng WH, Yang X, Wang H, Martinez SR, Chen SL, Meyers FJ, Bold RJ, Canter RJ. Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg. 2011 Aug; 254 (2):333-8 View PubMed Tseng WH, Jin L, Canter RJ, Martinez SR, Khatri VP, Gauvin J, Bold RJ, Wisner D, Taylor S, Chen SL. Surgical resident involvement is safe for common elective general surgery procedures. J Am Coll Surg. 2011 Jul; 213 (1):19-26; discussion 26-8 Epub 2011 Apr 13 View PubMed Tseng WH, Martinez SR, Tamurian RM, Chen SL, Bold RJ, Canter RJ. Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis. J Surg Oncol. 2011 Apr; 103 (5):390-4 Epub 2010 Dec 28 View PubMed Vanderveen KA, Canter RJ, Yin D, Cress RD, Bold RJ. Factors affecting treatment delivery and outcomes of patients with early-stage pancreatic adenocarcinoma. Pancreas 2011 Apr; 40 (3):480-2 View PubMed Tseng WH, Stevenson TR, Canter RJ, Chen SL, Khatri VP, Bold RJ, Martinez SR. Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum. Plast Reconstr Surg. 2010 Dec; 126 (6):1815-1824 View PubMed Beal SH, Martinez SR, Canter RJ, Chen SL, Khatri VP, Bold RJ. Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era. Med Oncol. 2010 Dec; 27 (4):1420-4 Epub 2010 Jan 05 View PubMed Coates JM, Galante JM, Bold RJ. Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death. J Surg Res. 2010 Dec; 164 (2):301-8 Epub 2009 Aug 07 View PubMed Martinez SR, Beal SH, Chen SL, Canter RJ, Khatri VP, Chen A, Bold RJ. Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2010 Nov 1; 78 (3):787-92 Epub 2010 July 07 View PubMed Muilenburg DJ, Coates JM, Virudachalam S, Bold RJ. Targeting Bcl-2-mediated cell death as a novel therapy in pancreatic cancer. J Surg Res. 2010 Oct; 163 (2):276-81 Epub 2010 Mar 12 View PubMed Coates JM, Martinez SR, Bold RJ, Chen SL. Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol. 2010 Sep 15; 102 (4):342-7 View PubMed Parsons CM, Muilenburg D, Bowles TL, Virudachalam S, Bold RJ. The role of Akt activation in the response to chemotherapy in pancreatic cancer. Anticancer Res. 2010 Sep; 30 (9):3279-89 View PubMed Harms NJ, Naderi S, Borys D, Bold RJ, Canter RJ. Complex diaphragm reconstruction using dermal collagen matrix after multivisceral resection of retroperitoneal sarcoma. J Thorac Cardiovasc Surg. 2010 Apr; 139 (4):1081-3 Epub 2009 Oct 23 View PubMed Canter RJ, Beal S, Borys D, Martinez SR, Bold RJ, Robbins AS. Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg. 2010 Feb; 210 (2):191-198.e2 Epub 2009 Dec 04 View PubMed Coates JM, Beal SH, Russo JE, Vanderveen KA, Chen SL, Bold RJ, Canter RJ. Negligible effect of selective preoperative biliary drainage on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy. Arch Surg. 2009 Sep; 144 (9):841-7 View PubMed Hausner SH, Abbey CK, Bold RJ, Gagnon MK, Marik J, Marshall JF, Stanecki CE, Sutcliffe JL. Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res. 2009 Jul 15; 69 (14):5843-50 Epub 2009 June 23 View PubMed Vanderveen KA, Chen SL, Yin D, Cress RD, Bold RJ. Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis. Cancer. 2009 Jun 1; 115 (11):2420-9 View PubMed Kim RH, Bold RJ, Kung HJ. ADI, autophagy and apoptosis: metabolic stress as a therapeutic option for prostate cancer. Autophagy. 2009 May; 5 (4):567-8 Epub 2009 May 20 View PubMed Galante JM, Mortenson MM, Bowles TL, Virudachalam S, Bold RJ. ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis. J Surg Res. 2009 Mar; 152 (1):18-25 Epub 2008 June 11 View PubMed Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, Gandour-Edwards R, Chuang FY, Bold RJ, Kung HJ. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009 Jan 15; 69 (2):700-8 View PubMed Bowles TL, Parsons C, Muilenburg DJ, Bold RJ. Targeted inhibition of AKT in pancreatic cancer. Current Cancer Therapy Reviews. 2009; 5(4):288-95. Bowles TL, Kim R, Galante J, Parsons CM, Virudachalam S, Kung HJ, Bold RJ. Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase. Int J Cancer. 2008 Oct 15; 123 (8):1950-5 View PubMed Vanderveen KA, Ramsamooj R, Bold RJ. A prospective, blinded trial of touch prep analysis versus frozen section for intraoperative evaluation of sentinel lymph nodes in breast cancer. Ann Surg Oncol. 2008 Jul; 15 (7):2006-11 Epub 2008 May 15 View PubMed Martinez SR, Robbins AS, Meyers FJ, Bold RJ, Khatri VP, Goodnight JE Jr. Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma. Cancer. 2008 Mar 1; 112 (5):1162-8 View PubMed Vanderveen K, Bold RJ. Effect of generational composition on the surgical workforce. Arch Surg. 2008 Mar; 143 (3):224-6 View PubMed Davies AM, Ruel C, Lara PN, Lau DH, Gumerlock PH, Bold R, Shibata S, Lenz HJ, Schenkein DP, Gandara DR. The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study. J Thorac Oncol. 2008 Jan; 3 (1):68-74 View PubMed Parsons CM, Sutcliffe JL, Bold RJ. Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg. 2008; 15 (4):429-35 Epub 2008 Aug 01 View PubMed Mortenson MM, Galante JG, Gilad O, Schlieman MG, Virudachalam S, Kung HJ, Bold RJ. BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer. J Cell Biochem. 2007 Dec 1; 102 (5):1171-9 View PubMed Redwine J, Bold RJ. Perioperative care of the patient with hemophilia undergoing urgent appendectomy. Arch Surg. 2007 Sep; 142 (9):894-7 View PubMed Vanderveen KA, Paterniti DA, Kravitz RL, Bold RJ. Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Ann Surg Oncol. 2007 May; 14 (5):1662-9 Epub 2007 Feb 07 View PubMed Wang H, Ryu J, Gandara D, Bold RJ, Urayama S, Tanaka M, Goldberg Z, Follette D, Narayan S, Lau D. A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. J Thorac Oncol. 2007 Feb; 2 (2):153-7 View PubMed Vanderveen KA, Schneider PD, Khatri VP, Goodnight JE, Bold RJ. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Ann Surg Oncol. 2006 Nov; 13 (11):1450-6 Epub 2006 Sept 29 View PubMed Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control. 2006 May; 17 (4):403-9 View PubMed Davies AM, Lara PN Jr, Mack PC, Gumerlock PH, Bold RJ, Gandara DR. Bortezomib-based combinations in the treatment of non-small-cell lung cancer. Clin Lung Cancer. 2005 Oct; 7 Suppl 2:S59-63 View PubMed Lara PN Jr, Bold RJ, Mack PC, Davies AM, Gumerlock PH, Gandara DR. Proteasome inhibition in small-cell lung cancer: preclinical rationale and clinical applications. Clin Lung Cancer. 2005 Oct; 7 Suppl 2:S67-71 View PubMed Mortenson MM, Ho HS, Bold RJ. An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer. Am J Surg. 2005 Sep; 190 (3):406-11 View PubMed Galante JM, Bowles TL, Khatri VP, Schneider PD, Goodnight JE Jr, Bold RJ. Experience and attitudes of surgeons toward palliation in cancer. Arch Surg. 2005 Sep; 140 (9):873-8; discussion 878-80 View PubMed Mortenson MM, Schlieman MG, Virudachalam S, Lara PN, Gandara DG, Davies AM, Bold RJ. Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer. Lung Cancer. 2005 Aug; 49 (2):163-70 View PubMed Fahy BN, Schlieman MG, Mortenson MM, Virudachalam S, Bold RJ. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib. Cancer Chemother Pharmacol. 2005 Jul; 56 (1):46-54 Epub 2005 Mar 25 View PubMed Bold RJ. A young surgeon's perspective. Arch Surg. 2005 Mar; 140 (3):254-7 View PubMed Demos SG, Bold RJ, White D, Ramsamooj R. Investigation of near infrared autofluorescence imaging for the detection of breast cancer. The Journal of Selected Topics in Quantum Electronics. 2005; 11(4):791-8. Mortenson MM, Schlieman MG, Virudachalam S, Bold RJ. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line. Cancer Chemother Pharmacol. 2004 Oct; 54 (4):343-53 Epub 2004 June 12 View PubMed Mortenson MM, Schneider PD, Khatri VP, Stevenson TR, Whetzel TP, Sommerhaug EJ, Goodnight JE Jr, Bold RJ. Immediate breast reconstruction after mastectomy increases wound complications: however, initiation of adjuvant chemotherapy is not delayed. Arch Surg. 2004 Sep; 139 (9):988-91 View PubMed Bold RJ, Goodnight JE Jr. Hilar cholangiocarcinoma: surgical and endoscopic approaches. Surg Clin North Am. 2004 Apr; 84 (2):525-42 View PubMed Fahy BN, Schlieman MG, Virudachalam S, Bold RJ. Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer. J Am Coll Surg. 2004 Apr; 198 (4):591-9 View PubMed Lara PN Jr, Davies AM, Mack PC, Mortenson MM, Bold RJ, Gumerlock PH, Gandara DR. Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy. Semin Oncol. 2004 Feb; 31 (1 Suppl 1):40-6 View PubMed Mortenson MM, Galante JM, Schlieman MG, Bold RJ. AKT: A novel target in pancreatic cancer therapy. Cancer Therapy. 2004; 2:227-38. Schlieman MG, Fahy BN, Ramsamooj R, Beckett L, Bold RJ. Incidence, mechanism and prognostic value of activated AKT in pancreas cancer. Br J Cancer. 2003 Dec 1; 89 (11):2110-5 View PubMed Khatri VP, Galante JM, Bold RJ, Schneider PD, Ramsamooj R, Goodnight JE Jr. Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment. Ann Surg Oncol. 2003 Nov; 10 (9):1118-22 View PubMed Monson K, Litvak DA, Bold RJ. Surgery in the aged population: surgical oncology. Arch Surg. 2003 Oct; 138 (10):1061-7 View PubMed Schlieman MG, Ho HS, Bold RJ. Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg. 2003 Sep; 138 (9):951-5; discussion 955-6 View PubMed Fahy BN, Schlieman M, Virudachalam S, Bold RJ. AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2. Br J Cancer. 2003 Jul 21; 89 (2):391-7 View PubMed Fahy BN, Schlieman MG, Virudachalam S, Bold RJ. Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer. J Surg Res. 2003 Jul; 113 (1):88-95 View PubMed Nawrocki ST, Bruns CJ, Harbison MT, Bold RJ, Gotsch BS, Abbruzzese JL, Elliott P, Adams J, McConkey DJ. Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther. 2002 Dec; 1 (14):1243-53 View PubMed Fahy BN, Bold RJ, Beckett L, Schneider PD. Modern parathyroid surgery: a cost-benefit analysis of localizing strategies. Arch Surg. 2002 Aug; 137 (8):917-22; discussion 922-3 View PubMed Althausen PL, Schneider PD, Bold RJ, Gupta MC, Goodnight JE Jr, Khatri VP. Multimodality management of a giant cell tumor arising in the proximal sacrum: case report. Spine (Phila Pa 1976). 2002 Aug 1; 27 (15):E361-5 View PubMed Stein M, Schneider PD, Ho HS, Eckert R, Urayama S, Bold RJ. Percutaneous transhepatic portography with intravascular ultrasonography for evaluation of venous involvement of hepatobiliary and pancreatic tumors. J Vasc Interv Radiol. 2002 Aug; 13 (8):805-14 View PubMed Fahy BN, Frey CF, Ho HS, Beckett L, Bold RJ. Morbidity, mortality, and technical factors of distal pancreatectomy. Am J Surg. 2002 Mar; 183 (3):237-41 View PubMed Schlieman M, Stein M, McVicar J, Bold R. Hepatic artery aneurysm within focal nodular hyperplasia. J Hepatol. 2002 Feb; 36 (2):302 View PubMed Bold RJ. Surgical management of breast cancer: today and tomorrow. Cancer Biother Radiopharm. 2002 Feb; 17 (1):1-9 View PubMed Bold RJ. Elective lymph node dissection in melanoma patients. Systematic review and meta-analysis of randomized controlled trials. Archives of Surgery. 2002; 137:461. Braley SC, Schneider PD, Bold RJ, Goodnight JE Jr, Khatri VP. Controlled tamponade of severe presacral venous hemorrhage: use of a breast implant sizer. Dis Colon Rectum. 2002 Jan; 45 (1):140-2 View PubMed Mortenson M, Bold RJ. Symptomatic pancreatic polypeptide-secreting tumor of the distal pancreas (PPoma). Int J Gastrointest Cancer. 2002; 32 (2-3):153-6 View PubMed Bold RJ, Schlieman M, Fahy BN. Sentinel lymph node biopsy for breast cancer. Cancer Biother Radiopharm. 2001 Oct; 16 (5):347-57 View PubMed Fahy BN, Bold RJ, Schneider PD, Khatri V, Goodnight JE Jr. Cost-benefit analysis of biopsy methods for suspicious mammographic lesions; discussion 994-5. Arch Surg. 2001 Sep; 136 (9):990-4 View PubMed Bold RJ, Virudachalam S, McConkey DJ. Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome. J Surg Res. 2001 Sep; 100 (1):11-7 View PubMed Bold RJ, Schneider PD, Khatri VP, Goodnight JE Jr. Resident experience and opinions about physician-assisted death for cancer patients. Arch Surg. 2001 Jan; 136 (1):60-4 View PubMed Bold RJ, Virudachalam S, McConkey DJ. BCL-2 expression correlates with metastatic potential in pancreatic cancer cells lines. Cancer. 2001; 92(5):1122-9. Fahy BN, Virudachalam S, Bold RJ. NF-kB regulates BCL-2 protein transcription in pancreatic cancer. Surgical Forum. 2001; 52:215-6. Bold RJ, Fahy BN. Practice patterns in sentinel lymph node biopsy. Journal of American College of Surgery. 2001; 193(4):466-7. Nguyen NT, Mayer KL, Bold RJ, Larson M, Foster S, Ho HS, Wolfe BM. Laparoscopic suturing evaluation among surgical residents. J Surg Res. 2000 Sep; 93 (1):133-6 View PubMed Neuhaus A, Bold RJ. Images in surgery. Small bowel stromal cell tumor. Am J Surg. 2000 Apr; 179 (4):252 View PubMed Bold RJ, Schneider PD, Goodnight JE. Sentinel node biopsy in breast cancer. Ann Surg 2000 Jan; 231 (1):148-9 View PubMed Bold RJ, Charnsangavej C, Cleary KR, Jennings M, Madray A, Leach SD, Abbruzzese JL, Pisters PW, Lee JE, Evans DB. Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. J Gastrointest Surg. 1999 May-Jun; 3 (3):233-43 View PubMed Bold RJ, Ota DM, Ajani JA, Mansfield PF. Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric cancer. Gastric Cancer. 1999 May; 2 (1):1-7 View PubMed Bold RJ, Chandra J, McConkey DJ. Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content. Ann Surg Oncol. 1999 Apr-May; 6 (3):279-85 View PubMed Bold RJ, Hess KR, Pearson AS, Grau AM, Sinicrope FA, Jennings M, McConkey DJ, Bucana CD, Cleary KR, Hallin PA, Chiao PJ, Abbruzzese JL, Evans DB. Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. J Gastrointest Surg. 1999 May-Jun; 3(3):263-77. View PubMed Pearlstone DB, Pisters PW, Bold RJ, Feig BW, Hunt KK, Yasko AW, Patel S, Pollack A, Benjamin RS, Pollock RE. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer. 1999 Jan 1; 85 (1):85-92 View PubMed Fahy B, Bold RJ. Epidemiology and molecular genetics of colorectal cancer. Surgical Oncology. 1999; 7:115-23. Bouvet M, Bold RJ, Lee J, Evans DB, Abbruzzese JL, Chiao PJ, McConkey DJ, Chandra J, Chada S, Fang B, Roth JA. Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. Ann Surg Oncol. 1998 Dec; 5 (8):681-8 View PubMed Bold RJ, Ishizuka J, Yao CZ, Townsend CM Jr, Thompson JC. Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptors status. Anticancer Res. 1998 Nov-Dec; 18 (6A):4051-6 View PubMed Bold RJ, Winchester DJ, Madary AR, Gregurich MA, Mansfield PF. Prospective, randomized trial of Doppler-assisted subclavian vein catheterization. Arch Surg. 1998 Oct; 133 (10):1089-93 View PubMed Bold RJ, Mansfield PF, Berger DH, Pollock RE, Singletary SE, Ames FC, Balch CM, Hohn DC, Ross MI. Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection. Am J Surg. 1998 Sep; 176 (3):239-43 View PubMed Bold RJ. Preoperative chemoradiation: A possible treatment for Klatskin's tumor. Hospital Physician. 1998; 34(12):10. Bold RJ, Kim HJ, Ishizuka J, Townsend CM Jr, Thompson JC. A human gastric cancer cell line possesses a functional receptor for gastrin-releasing peptide. Cancer Invest. 1998; 16 (1):12-7 View PubMed Evans DB, Pisters PW, Lee JE, Bold RJ, Charnsangavej C, Janjan NA, Wolff RA, Abbruzzese JL. Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. J Hepatobiliary Pancreat Surg. 1998; 5 (3):242-50 View PubMed Bold RJ, Evans DB, Cleary KR, Bucana CD, McConkey DJ. Expression of the proapoptotic gene bak predicts recurrence and decreased survival of resectable pancreatic cancer. Surgical Forum, American College of Surgeons. 1998; 49:403-4. Bold RJ, Kroll SS, Baldwin BJ, Ross MI, Singletary SE. Local rotational flaps for breast conservation therapy as an alternative to mastectomy. Ann Surg Oncol. 1997 Oct-Nov; 4 (7):540-4 View PubMed Bold RJ, Termuhlen PM, McConkey DJ. Apoptosis, cancer and cancer therapy. Surgical Oncology. 1997; 6(3):133-42. Hirai A, Bold RJ, Ishizuka J, Hirai M, Townsend CM Jr, Thompson JC. Hyperphosphorylation of retinoblastoma protein and stimulation of growth by okadaic acid in human pancreatic cancer. Dig Dis Sci. 1996 Oct; 41 (10):1975-80 View PubMed Bold RJ, Ishizuka J, Townsend CM Jr, Thompson JC. All-trans-retinoic acid inhibits growth of human pancreatic cancer cell lines. Pancreas. 1996 Mar; 12 (2):189-95 View PubMed Yao CZ, Ishizuka J, Bold RJ, Sperling HE, Townsend CM Jr, Thompson JC. Human monoclonal antibody against colon cancer. Cancer Invest. 1996; 14 (3):211-7 View PubMed Bold RJ, Ishizuka J, Townsend CM Jr. Progress toward hormonal therapy of gastrointestinal cancer. Ann Surg. 1996 Jan; 223 (1):4-11 View PubMed Organ JR CH, Bold RJ. Contempo: Surgery. Journal of the American Medical Association. 1996; 275(23):1855-7. Bold RJ, Ishizuka J, Townsend CM Jr, Thompson JC. Secretin potentiates cholecystokinin-stimulated amylase release by AR4-2J cells via a stimulation of phospholipase C. J Cell Physiol. 1995 Oct; 165 (1):172-6 View PubMed Bold RJ, Ishizuka J, Rajaraman S, Perez-Polo JR, Townsend CM Jr, Thompson JC. Nerve growth factor as a mitogen for a pancreatic carcinoid cell line. J Neurochem. 1995 Jun; 64 (6):2622-8 View PubMed Yao CZ, Bold RJ, Ishizuka J, Townsend CM Jr, Thompson JC. Growth of mouse hepatocytes is stimulated by gastrin. J Cell Physiol. 1995 Jun; 163 (3):532-7 View PubMed Ishizuka J, Bold RJ, Townsend CM Jr, Thompson JC. Role of calcium in the regulation of ornithine decarboxylase enzyme activity in mouse colon cancer cells. Cancer Invest. 1995; 13 (2):181-7 View PubMed Bold RJ, Lowry PS, Ishizuka J, Battey JF, Townsend CM Jr, Thompson JC. Bombesin stimulates the in vitro growth of a human gastric cancer cell line. J Cell Physiol. 1994 Dec; 161 (3):519-25 View PubMed Bold RJ, Alpard S, Ishizuka J, Townsend CM Jr, Thompson JC. Growth-regulatory effect of gastrin on human colon cancer cell lines is determined by protein kinase a isoform content. Regul Pept. 1994 Aug 31; 53 (1):61-70 View PubMed Bold RJ, Ishizuka J, Townsend CM Jr, Thompson JC. Gastrin stimulates growth of human colon cancer cells via a receptor other than CCK-A or CCK-B. Biochem Biophys Res Commun. 1994 Aug 15; 202 (3):1222-6 View PubMed Evers BM, Bold RJ, Ehrenfried JA, Li J, Townsend CM Jr, Klimpel GR. Characterization of functional neurotensin receptors on human lymphocytes. Surgery. 1994 Aug; 116 (2):134-9; discussion 139-40 View PubMed Bold RJ, Warren RE, Ishizuka J, Cho-Chung YS, Townsend CM Jr, Thompson JC. Experimental gene therapy of human colon cancer. Surgery. 1994 Aug; 116 (2):189-95; discussion 195-6 View PubMed Ishizuka J, Townsend CM Jr, Bold RJ, Martinez J, Rodriguez M, Thompson JC. Effects of gastrin on 3',5'-cyclic adenosine monophosphate, intracellular calcium, and phosphatidylinositol hydrolysis in human colon cancer cells. Cancer Res. 1994 Apr 15; 54 (8):2129-35 View PubMed Ishizuka J, Bold RJ, Townsend CM Jr, Thompson JC. In vitro relationship between magnesium and insulin secretion. Magnes Res. 1994 Mar; 7 (1):17-22 View PubMed Townsend CM Jr, Bold RJ, Ishizuka J. Gastrointestinal hormones and cell proliferation. Surg Today. 1994; 24 (9):772-7 View PubMed Bold RJ, Evers BM, Sperlin HE, Gomez G, Ishizuka J, Townsend JR CM, Thompson JC. Gastrointestinal hormones receptors and pancreatic cancer. International Journal of Pancreatology. 1994; 16:240-1. Bold RJ, Evers BM, Ishizuka J, Townsend Jr CM, Thompson JC. Functional responses of the endocrine cell line (BON) transfected with the human bombesin receptor. Surgical Forum. 1994; 45:158-60. Bold RJ, Hannink M, Donoghue DJ. Functions of the mos oncogene family and associated gene products. Cancer Surv. 1986; 5 (2):243-55 View PubMed Bold RJ, Donoghue DJ. Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors. Mol Cell Biol. 1985 Nov; 5 (11):3131-8 View PubMed PST-20568801 الصفحة الرئيسية المنشورات